Detalles de la búsqueda
1.
Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).
Prostate
; 78(12): 889-895, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29707790
2.
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
JAMA
; 319(9): 896-905, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29509865
3.
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.
JAMA Netw Open
; 4(7): e2116536, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34292336
4.
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.
Eur Urol
; 77(1): 3-10, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30992160
5.
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry.
Prostate Cancer Prostatic Dis
; 22(3): 420-427, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30643173
6.
Clinical Outcomes of First-line Abiraterone Acetate or Enzalutamide for Metastatic Castration-resistant Prostate Cancer After Androgen Deprivation Therapy + Docetaxel or ADT Alone for Metastatic Hormone-sensitive Prostate Cancer.
Clin Genitourin Cancer
; 16(2): 130-134, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29331381
7.
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.
Int J Radiat Oncol Biol Phys
; 101(4): 883-888, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29976500
Resultados
1 -
7
de 7
1
Próxima >
>>